| Literature DB >> 26660713 |
Nancy Rivas-Tolosa1, Ariadna Ortiz-Brugués2, Tomás Toledo-Pastrana3, Manel Baradad2, Víctor Traves4, Virtudes Soriano5, Verónica Sanmartín2, Celia Requena1, Rosa Martí2, Eduardo Nagore1.
Abstract
Locoregional cutaneous metastases of melanoma (LCMM) represent a therapeutic challenge. Many treatment options are available with varying results. The combination of cryotherapy and imiquimod, two treatments with a possible synergistic effect, has not yet been described for treating this disease. In this paper, we aimed to show the response of LCMM to cryotherapy combined with topical imiquimod 5%. A retrospective review of 20 patients diagnosed with LCMM and treated with cryotherapy combined with topical imiquimod 5% between November 2000 and May 2014 at three institutions was performed. The locoregional cutaneous response was evaluated. After a mean of five sessions, 13 patients (65%) responded to treatment, eight (40%) of these completely and five (25%) partially. Systemic disease progressed in 16 (80%) patients. Cryotherapy followed by topical imiquimod 5% is simple to apply, has minimal adverse effects and provides response rates similar to other, more complex treatment options.Entities:
Keywords: cryotherapy; imiquimod; locoregional cutaneous metastases; melanoma; treatment
Mesh:
Substances:
Year: 2015 PMID: 26660713 DOI: 10.1111/1346-8138.13197
Source DB: PubMed Journal: J Dermatol ISSN: 0385-2407 Impact factor: 4.005